If you or someone you know struggles with restless nights and daytime fatigue, sleep apnea might be the culprit. But what if a simple pill could offer relief, potentially replacing bulky masks and machines?
A new drug, 'Apnimed,' is making headlines for its potential to treat obstructive sleep apnea (OSA). It's currently in late-stage clinical trials, showing promising results.
Apnimed's drug, AD109, recently completed a successful Phase 3 trial (SYNOPSE).